Psoriasis is a common chronic
skin disease. Recent studies demonstrated that
IL-20 and
IL-22,
cytokines produced by keratinocytes and T cells, respectively, both inhibit keratinocyte terminal differentiation and induce
psoriasis-like epidermis alterations. Here, we investigated the relationship between these mediators. Although
IL-20 was not able to regulate
IL-22 production,
IL-22 induced
IL-20 mRNA and
protein in human keratinocytes. However,
IL-22 had only a minimal effect, if any, on IL-19 and IL-26. Cutaneous
IL-20 was also elevated in mice following
IL-22 application. Accordingly, some of IL-22's effects on differentiation-regulating genes were partially mediated by an endogenous, secreted
protein and attenuated by anti-IL-20 Ab. Like
IL-22,
IL-17A and
TNF-alpha induced
IL-20 in keratinocytes, whereas IFN-gamma and
IL-20 itself did not. Furthermore,
IL-17A and
TNF-alpha individually strengthened the IL-22-induced
IL-20 production. In lesional skin of
psoriasis patients, highly elevated
IL-20 levels strongly correlated with
IL-22, and to a lesser extent, with
IL-17A and
TNF-alpha. As previously shown for
IL-22,
IL-20 blood levels correlated with the disease severity, although with a lower significance. This study demonstrates that a T-cell mediator induces a tissue cell mediator with similar effects to its own and therefore suggests the existence of a novel type of pathogenetic cascade.